188 related articles for article (PubMed ID: 34262039)
1. Metastatic heterogeneity of the consensus molecular subtypes of colorectal cancer.
Eide PW; Moosavi SH; Eilertsen IA; Brunsell TH; Langerud J; Berg KCG; Røsok BI; Bjørnbeth BA; Nesbakken A; Lothe RA; Sveen A
NPJ Genom Med; 2021 Jul; 6(1):59. PubMed ID: 34262039
[TBL] [Abstract][Full Text] [Related]
2. De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity.
Moosavi SH; Eide PW; Eilertsen IA; Brunsell TH; Berg KCG; Røsok BI; Brudvik KW; Bjørnbeth BA; Guren MG; Nesbakken A; Lothe RA; Sveen A
Genome Med; 2021 Sep; 13(1):143. PubMed ID: 34470666
[TBL] [Abstract][Full Text] [Related]
3. Classification of patients with metastatic colorectal cancer into consensus molecular subtypes into real-world: A pilot study.
González-Montero J; Burotto M; Valenzuela G; Mateluna D; Buen-Abad F; Toro J; Barajas O; Marcelain K
World J Clin Oncol; 2023 Oct; 14(10):409-419. PubMed ID: 37970108
[TBL] [Abstract][Full Text] [Related]
4. Exploratory analyses of consensus molecular subtype-dependent associations of
Smeby J; Sveen A; Bergsland CH; Eilertsen IA; Danielsen SA; Eide PW; Hektoen M; Guren MG; Nesbakken A; Bruun J; Lothe RA
ESMO Open; 2019; 4(3):e000523. PubMed ID: 31321083
[TBL] [Abstract][Full Text] [Related]
5. The prognostic impact of consensus molecular subtypes (CMS) and its predictive effects for bevacizumab benefit in metastatic colorectal cancer: molecular analysis of the AGITG MAX clinical trial.
Mooi JK; Wirapati P; Asher R; Lee CK; Savas P; Price TJ; Townsend A; Hardingham J; Buchanan D; Williams D; Tejpar S; Mariadason JM; Tebbutt NC
Ann Oncol; 2018 Nov; 29(11):2240-2246. PubMed ID: 30247524
[TBL] [Abstract][Full Text] [Related]
6. Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies.
Sveen A; Bruun J; Eide PW; Eilertsen IA; Ramirez L; Murumägi A; Arjama M; Danielsen SA; Kryeziu K; Elez E; Tabernero J; Guinney J; Palmer HG; Nesbakken A; Kallioniemi O; Dienstmann R; Lothe RA
Clin Cancer Res; 2018 Feb; 24(4):794-806. PubMed ID: 29242316
[No Abstract] [Full Text] [Related]
7. Seed and Soil: Consensus Molecular Subgroups (CMS) and Tumor Microenvironment Features Between Primary Lesions and Metastases of Different Organ Sites in Colorectal Cancer.
Luo Q; Quan Y; Liu W; Wu Z; Qiu W; Liang W; Yang P; Huang Q; Li G; Wei J; Wang Q; Shen F; Li W; He F; Cao J
Cancer Manag Res; 2024; 16():225-243. PubMed ID: 38525373
[TBL] [Abstract][Full Text] [Related]
8. CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models.
Eide PW; Bruun J; Lothe RA; Sveen A
Sci Rep; 2017 Nov; 7(1):16618. PubMed ID: 29192179
[TBL] [Abstract][Full Text] [Related]
9. Consensus molecular subtype classification of colorectal adenomas.
Komor MA; Bosch LJ; Bounova G; Bolijn AS; Delis-van Diemen PM; Rausch C; Hoogstrate Y; Stubbs AP; de Jong M; Jenster G; van Grieken NC; Carvalho B; Wessels LF; Jimenez CR; Fijneman RJ; Meijer GA;
J Pathol; 2018 Nov; 246(3):266-276. PubMed ID: 29968252
[TBL] [Abstract][Full Text] [Related]
10. Consensus molecular subtypes (CMS) in metastatic colorectal cancer - personalized medicine decision.
Rebersek M
Radiol Oncol; 2020 May; 54(3):272-277. PubMed ID: 32463385
[TBL] [Abstract][Full Text] [Related]
11. Consensus Molecular Subtypes of Colorectal Cancer and their Clinical Implications.
Thanki K; Nicholls ME; Gajjar A; Senagore AJ; Qiu S; Szabo C; Hellmich MR; Chao C
Int Biol Biomed J; 2017; 3(3):105-111. PubMed ID: 28825047
[TBL] [Abstract][Full Text] [Related]
12. CMS-dependent prognostic impact of KRAS and BRAFV600E mutations in primary colorectal cancer.
Smeby J; Sveen A; Merok MA; Danielsen SA; Eilertsen IA; Guren MG; Dienstmann R; Nesbakken A; Lothe RA
Ann Oncol; 2018 May; 29(5):1227-1234. PubMed ID: 29518181
[TBL] [Abstract][Full Text] [Related]
13. Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy.
Becht E; de Reyniès A; Giraldo NA; Pilati C; Buttard B; Lacroix L; Selves J; Sautès-Fridman C; Laurent-Puig P; Fridman WH
Clin Cancer Res; 2016 Aug; 22(16):4057-66. PubMed ID: 26994146
[TBL] [Abstract][Full Text] [Related]
14. The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications.
Soldevilla B; Carretero-Puche C; Gomez-Lopez G; Al-Shahrour F; Riesco MC; Gil-Calderon B; Alvarez-Vallina L; Espinosa-Olarte P; Gomez-Esteves G; Rubio-Cuesta B; Sarmentero J; La Salvia A; Garcia-Carbonero R
Eur J Cancer; 2019 Dec; 123():118-129. PubMed ID: 31678770
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic subtypes predict outcomes in colorectal cancer.
Kasurinen J; Beilmann-Lehtonen I; Kaprio T; Hagström J; Haglund C; Böckelman C
Acta Oncol; 2023 Mar; 62(3):245-252. PubMed ID: 36867078
[TBL] [Abstract][Full Text] [Related]
16. Characterizing heterogeneity along EMT and metabolic axes in colorectal cancer reveals underlying consensus molecular subtype-specific trends.
Sehgal M; Ramu S; Vaz JM; Ganapathy YR; Muralidharan S; Venkatraghavan S; Jolly MK
Transl Oncol; 2024 Feb; 40():101845. PubMed ID: 38029508
[TBL] [Abstract][Full Text] [Related]
17. [Characterization of patients with sporadic colorectal cancer following the new Consensus Molecular Subtypes (CMS)].
Wielandt AM; Villarroel C; Hurtado C; Simian D; Zamorano D; Martínez M; Castro M; Vial MT; Kronberg U; López-Kostner F
Rev Med Chil; 2017 Apr; 145(4):419-430. PubMed ID: 28748988
[TBL] [Abstract][Full Text] [Related]
18. Consensus molecular subtypes of primary colon tumors and their hepatic metastases.
Lau YC; Schmeier S; Frizelle F; Purcell R
Future Sci OA; 2021 Aug; 7(7):FSO722. PubMed ID: 34258029
[TBL] [Abstract][Full Text] [Related]
19. Clinical Value of Consensus Molecular Subtypes in Colorectal Cancer: A Systematic Review and Meta-Analysis.
Ten Hoorn S; de Back TR; Sommeijer DW; Vermeulen L
J Natl Cancer Inst; 2022 Apr; 114(4):503-516. PubMed ID: 34077519
[TBL] [Abstract][Full Text] [Related]
20. A Clinically Applicable Gene-Expression Classifier Reveals Intrinsic and Extrinsic Contributions to Consensus Molecular Subtypes in Primary and Metastatic Colon Cancer.
Piskol R; Huw L; Sergin I; Kljin C; Modrusan Z; Kim D; Kljavin N; Tam R; Patel R; Burton J; Penuel E; Qu X; Koeppen H; Sumiyoshi T; de Sauvage F; Lackner MR; de Sousa E Melo F; Kabbarah O
Clin Cancer Res; 2019 Jul; 25(14):4431-4442. PubMed ID: 31004000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
